Skip to main content

Table 3 Univariate and multivariate analyses of OS in 73 patients with LS-SCLC treated with early CCRT

From: Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Variable

Univariate analysis

Multivariate analysis

Relative risk

95% CI

P value

Relative risk

95% CI

P value

Sex, male

1.77

0.79–4.71

0.1933

–

–

 

Age ≥ 70 years

2.28

1.18–4.20

0.8471

0.88

0.39–1.84

0.7511

ECOG-PS = 0

0.86

0.45–1.67

0.6398

0.83

0.42–1.64

0.5840

Clinical stage III

0.95

0.45–2.23

0.8988

0.74

0.32–1.85

0.5002

Pre-existing ILAs

2.29

0.97–4.78

0.0338

2.51

1.02–5.62

0.0460

  1. OS, overall survival; LS-SCLC, limited-stage small-cell lung cancer; CCRT, concurrent chemoradiotherapy; CI, confidence interval; ECOG-PS, Eastern Cooperative Oncology Group performance status; ILA, interstitial lung abnormality
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us